These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4623893)

  • 21. [Glibenclamide (Daonil Euglucon)].
    Frey H
    Tidsskr Nor Laegeforen; 1971 Aug; 91(24):1766-7. PubMed ID: 4999954
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical evaluation of a new sulfonylurea (Ro-6-4563) in the treatment of stable diabetes in adults].
    Artega A; Soto S; Eyzaguirre J; Foradori A; Alliende ME
    Rev Med Chil; 1972 Jun; 100(6):635-8. PubMed ID: 5083349
    [No Abstract]   [Full Text] [Related]  

  • 23. A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024).
    Lentini S; Bossini A; Pirola LC
    Arzneimittelforschung; 1972 Jul; 22(7):1169-73. PubMed ID: 4678124
    [No Abstract]   [Full Text] [Related]  

  • 24. Glibenclamide (HB 419, Daonil) in the clinical practice of diabetes.
    Krall LP; Sinha S; Goldstein HH
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:57-62. PubMed ID: 5005132
    [No Abstract]   [Full Text] [Related]  

  • 25. [Personal experience on the use of glybenclamide (a new oral hypoglycemic agent)].
    Rodríguez-Miñón JL; Arrieta F; Herrera JL
    Rev Clin Esp; 1970 May; 117(4):371-4. PubMed ID: 5471526
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prolonged treatment with glibenclamide in various types of diabetic patient].
    Lozano-Castaneda O; Garcia Viveros M; Gomez Peréz FJ; Rull JA
    Prensa Med Mex; 1971 Oct; 36(9):451-5. PubMed ID: 5002035
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment with glibenclamide in maturity-onset diabetes mellitus.
    Persson I; Madsen SN
    Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113
    [No Abstract]   [Full Text] [Related]  

  • 28. Glibenclamide therapy in diabetes mellitus.
    Bhattia SK; Hadden DR; Montgomery DA; Weaver JA
    Br Med J; 1970 Jun; 2(5709):570-2. PubMed ID: 5005518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glibenclamide: its therapeutic effect in diabetes mellitus].
    Concha E; Veit O
    Rev Med Chil; 1971 Mar; 99(3):217-9. PubMed ID: 4999506
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diabetes mellitus. XII. Oral diabetes therapy].
    Bruns W; Michaelis D; Wappler E
    Z Arztl Fortbild (Jena); 1971 Feb; 65(3):125-30. PubMed ID: 5575105
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic trial of a new antidiabetic with vascular action: 1702 SE].
    Jaillard J; Warembourg H
    Lille Med; 1972 Oct; 17(9):Suppl 6:1332-6. PubMed ID: 4657429
    [No Abstract]   [Full Text] [Related]  

  • 32. [A new antidiabetic agent: glyclazide. A study of glycemic regulation].
    Bour H; Denard Y; Plauchu M; Rathery M; Simonin R; Thervet F; Warembourg H
    Nouv Presse Med; 1974 Feb; 3(5):249-51. PubMed ID: 4819946
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical testing of a sulfonylurea preparation (glibenclamide)].
    Sigroth K; Steen B; Svanborg A
    Lakartidningen; 1969 Nov; 66(45):4647-50. PubMed ID: 4996889
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide. II. Repeated administration in combination with glucose.
    Haupt E; Köberich W; Beyer J; Schöffling K
    Diabetologia; 1971 Dec; 7(6):455-60. PubMed ID: 5004179
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experiences with Glibornurid, a new sulfonylurea derivative for the treatment of diabetes in adults].
    Rosenstiel K
    Med Welt; 1972 Sep; 23(36):1214-6. PubMed ID: 5079616
    [No Abstract]   [Full Text] [Related]  

  • 36. A study of single dose tolbutamide therapy in diabetes mellitus.
    Omar JB; Mittal HS; Goyal BM; Arora A
    J Indian Med Assoc; 1970 Sep; 55(5):157-61. PubMed ID: 5485877
    [No Abstract]   [Full Text] [Related]  

  • 37. Seminars on diabetes. II. Principles of management.
    Can Med Assoc J; 1971 Nov; 105(9):972-3 passim. PubMed ID: 5150198
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical experience with RO 6-4563 (Glibornuride) (a new oral hypoglycemic agent)].
    Rodríguez-Miñón JL; Herrera Pombo JL; Marrón JA
    Rev Clin Esp; 1971 Dec; 123(5):439-42. PubMed ID: 5160567
    [No Abstract]   [Full Text] [Related]  

  • 39. [Behavior of lactate and pyruvate in diabetics during ambulatory treatment with biguanides or with a combination of biguanides and sulfonylureas. II].
    Lunetta M; Presti C; Mughini MT; Mughini L
    Clin Ter; 1980 Jun; 93(6):657-72. PubMed ID: 6775864
    [No Abstract]   [Full Text] [Related]  

  • 40. Glucose tolerance in diabetes mellitus during treatment with the sulfonylurea hypoglycemic agents.
    Herman JB
    Isr J Med Sci; 1966; 2(6):733-7. PubMed ID: 5956689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.